Fc-optimized CD40 Agonistic Antibody Induces Tertiary Lymphoid Structures and Systemic Antitumor Immunity in Metastatic Cancer Patients
Single-cell RNA-seq · mouse · 33 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 33 samples: 33 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancerCancer cell · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE298036_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1267139 and SRA study SRP587349. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 33 sample titles: 33 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9005501 Sample 1004 CD45+ cells, GEX
- GSM9005502 Sample 1004 CD45+ cells, HTO
- GSM9005503 Sample 1004 CD45+ cells, TCR
- GSM9005504 Sample 1005 CD45+ cells, GEX
- GSM9005505 Sample 1005 CD45+ cells, HTO
- GSM9005506 Sample 1005 CD45+ cells, TCR
- GSM9005507 Sample 1006 CD45+ cells, GEX
- GSM9005508 Sample 1006 CD45+ cells, HTO
- GSM9005509 Sample 1006 CD45+ cells, TCR
- GSM9005510 Sample 1007 CD45+ cells, GEX
- GSM9005511 Sample 1007 CD45+ cells, HTO
- GSM9005512 Sample 1007 CD45+ cells, TCR
- GSM9005513 Sample 1008 CD45+ cells, GEX
- GSM9005514 Sample 1008 CD45+ cells, HTO
- GSM9005515 Sample 1008 CD45+ cells, TCR
- GSM9005516 Sample 1009 CD45+ cells, GEX
- GSM9005517 Sample 1009 CD45+ cells, HTO
- GSM9005518 Sample 1009 CD45+ cells, TCR
- GSM9005519 Sample 1010 CD45+ cells, GEX
- GSM9005520 Sample 1010 CD45+ cells, HTO
- GSM9005521 Sample 1010 CD45+ cells, TCR
- GSM9005522 Sample 1011 CD45+ cells, GEX
- GSM9005523 Sample 1011 CD45+ cells, HTO
- GSM9005524 Sample 1011 CD45+ cells, TCR
- GSM9005525 Sample 1001 CD45+ cells, GEX
- GSM9005526 Sample 1001 CD45+ cells, HTO
- GSM9005527 Sample 1001 CD45+ cells, TCR
- GSM9005528 Sample 1002 CD45+ cells, GEX
- GSM9005529 Sample 1002 CD45+ cells, HTO
- GSM9005530 Sample 1002 CD45+ cells, TCR
- GSM9005531 Sample 1003 CD45+ cells, GEX
- GSM9005532 Sample 1003 CD45+ cells, HTO
- GSM9005533 Sample 1003 CD45+ cells, TCR
- GSE291447 Targeting CD11b+ regulatory B cells via RAS/RAF/PI3K pathway inhibition augments response to immune checkpoint blockade or CD40 agonism in metastatic melanoma 60 samples shares cd40, metastatic
- GSE290982 ATOR-4066, a Neo-X-Prime bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell dependent tumor immunity 52 samples shares cd40, antibody
- GSE302373 Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer 10 samples shares structures, tertiary
- GSE325580 NEMO lysine mutant mice reveal ROS-RelA signaling required for optimal CD40-induced humoral immunity [NEMODK_CUTTAG] 60 samples shares cd40
- GSE248155 Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma 31 samples shares cd40
- GSE279659 CD40L-targeting engineered regulatory T cells as a novel cell therapy approach for T cell mediated inflammatory diseases 27 samples shares cd40
- GSE292938 Targeting the CD40 Co-stimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas 24 samples shares cd40
- GSE248154 Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma [4NQO_model] 19 samples shares cd40
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.